Breaking News: Japanese MHLW Grants Orphan Drug Designation to Krystal Biotech’s Beremagene Geperpavec-SVDT-B-Vec!
Welcome to the World of Genetic Medicines! Exciting News from Krystal Biotech PITTSBURGH, Dec. 19, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, today announced that the Japan Ministry of…